These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29095102)

  • 21. Statistical comparison of excystation methods in Cryptosporidium parvum oocysts.
    Pecková R; Stuart PD; Sak B; Květoňová D; Kváč M; Foitová I
    Vet Parasitol; 2016 Oct; 230():1-5. PubMed ID: 27884435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VIABILITY AND INFECTIVITY OF CRYOPRESERVED PLASMODIUM VIVAX SPOROZOITES.
    Patrapuvich R; Lerdpanyangam K; Jenwithisuk R; Rungin S; Boonhok R; Duangmanee A; Yimamnuaychok N; Sattabongkot J
    Southeast Asian J Trop Med Public Health; 2016 Mar; 47(2):171-81. PubMed ID: 27244953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the viability of Cryptosporidium parvum oocysts with the induction ratio of hsp70 mRNA production in manure.
    Garcés-Sanchez G; Wilderer PA; Horn H; Munch JC; Lebuhn M
    J Microbiol Methods; 2013 Sep; 94(3):280-9. PubMed ID: 23747597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete development and multiplication of Cryptosporidium hominis in cell-free culture.
    Hijjawi N; Estcourt A; Yang R; Monis P; Ryan U
    Vet Parasitol; 2010 Apr; 169(1-2):29-36. PubMed ID: 20092948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiplication of the waterborne pathogen Cryptosporidium parvum in an aquatic biofilm system.
    Koh W; Clode PL; Monis P; Thompson RC
    Parasit Vectors; 2013 Sep; 6():270. PubMed ID: 24330483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanical transport and transmission of Cryptosporidium parvum oocysts by wild filth flies.
    Graczyk TK; Fayer R; Knight R; Mhangami-Ruwende B; Trout JM; Da Silva AJ; Pieniazek NJ
    Am J Trop Med Hyg; 2000; 63(3-4):178-83. PubMed ID: 11388511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro excystation of Cryptosporidium muris oocysts and viability of released sporozoites in different incubation media.
    Melicherová J; Mazourová V; Valigurová A
    Parasitol Res; 2016 Mar; 115(3):1113-21. PubMed ID: 26678654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryptosporidium parvum: in vitro cultivation in Madin-Darby canine kidney cells.
    Gut J; Petersen C; Nelson R; Leech J
    J Protozool; 1991; 38(6):72S-73S. PubMed ID: 1818215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro cultivation model of Cryptosporidium parvum in MDCK cells and its development].
    Chen F; Huang KH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Jun; 27(3):219-22. PubMed ID: 19852362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new in vitro model using small intestinal epithelial cells to enhance infection of Cryptosporidium parvum.
    Varughese EA; Bennett-Stamper CL; Wymer LJ; Yadav JS
    J Microbiol Methods; 2014 Nov; 106():47-54. PubMed ID: 25072838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity.
    Zhang X; Kim CY; Worthen T; Witola WH
    Int J Parasitol; 2018 Jul; 48(8):649-656. PubMed ID: 29530646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA-Seq analysis during the life cycle of Cryptosporidium parvum reveals significant differential gene expression between proliferating stages in the intestine and infectious sporozoites.
    Lippuner C; Ramakrishnan C; Basso WU; Schmid MW; Okoniewski M; Smith NC; Hässig M; Deplazes P; Hehl AB
    Int J Parasitol; 2018 May; 48(6):413-422. PubMed ID: 29432770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Cryptosporidium parvum development in various cell lines for screening in vitro drug testing.
    Siripanth C; Punpoowong B; Amarapal P; Thima N; Eampokalap B; Kaewkungwal J
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):540-6. PubMed ID: 15689063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A highly divergent 33 kDa Cryptosporidium parvum antigen.
    Jenkins MC; Widmer G; O'Brien C; Bauchan G; Murphy C; Santin M; Fayer R
    J Parasitol; 2014 Aug; 100(4):527-31. PubMed ID: 24601821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating viability of Cryptosporidium parvum oocysts using reverse transcriptase-polymerase chain reaction (RT-PCR) directed at mRNA encoding amyloglucosidase.
    Jenkins MC; Trout J; Abrahamsen MS; Lancto CA; Higgins J; Fayer R
    J Microbiol Methods; 2000 Dec; 43(2):97-106. PubMed ID: 11121608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The transcriptome of Cryptosporidium oocysts and intracellular stages.
    Matos LVS; McEvoy J; Tzipori S; Bresciani KDS; Widmer G
    Sci Rep; 2019 May; 9(1):7856. PubMed ID: 31133645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptosporidium parvum sporozoites contain glutathione.
    Al-Adhami BH; Nichols RA; Kusel JR; O'Grady J; Smith HV
    Parasitology; 2006 Nov; 133(Pt 5):555-63. PubMed ID: 16817993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific and quantitative detection and identification of Cryptosporidium hominis and C. parvum in clinical and environmental samples.
    Yang R; Murphy C; Song Y; Ng-Hublin J; Estcourt A; Hijjawi N; Chalmers R; Hadfield S; Bath A; Gordon C; Ryan U
    Exp Parasitol; 2013 Sep; 135(1):142-7. PubMed ID: 23838581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of three common hospital liquid germicides to inactivate Cryptosporidium parvum oocysts.
    Wilson JA; Margolin AB
    J Hosp Infect; 1999 Jul; 42(3):231-7. PubMed ID: 10439996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.